OSR Health Announces Nasdaq Clarification on Shareholder Loyalty Program
OSR Health, Inc. (NASDAQ:OSRH) has announced that the Nasdaq Stock Market has clarified its position regarding the company's Shareholder Loyalty Contingent Value Rights (CVR) program. According to Nasdaq, the implementation of this program will not result in any mechanical adjustments to the price of OSR Health's common stock, either during the distribution of the CVRs or when additional shares are delivered to enrolled shareholders. This means that there will be no ex-date or downward price adjustment related to the CVR distribution, allowing the value of OSRH shares to be determined solely by market forces.
The record date for shareholders to be eligible for the program is August 14, 2026. Those who hold their shares by this date and complete the enrollment process will receive one CVR for each share of OSRH common stock they own. Additionally, enrolled shareholders who maintain their holdings continuously will be eligible to receive extra shares of common stock at no cost, contingent upon meeting defined closing-price thresholds at four measurement dates over the next twelve months.
For Your Trading Desk
Sponsor Spike Success.
Peter Hwang, CEO of OSR Health, expressed that this communication from Nasdaq provides essential clarity regarding the CVR program's structure. He emphasized that investors who enroll and hold their shares will benefit from additional shares, with their value determined by the market's assessment of the company's progress rather than any mechanical adjustments. Tim Smith, Head of Investor Relations, highlighted the company's commitment to ensuring that all eligible shareholders can easily participate in the program, aiming to maximize participation for those who believe in OSR Health's vision.
While Nasdaq's clarification pertains specifically to the treatment of the CVR distribution for price-adjustment purposes, it does not imply any endorsement of the program or investment in OSRH. The distribution of CVRs and delivery of shares remain subject to the company's ongoing regulatory processes. OSR Health is dedicated to advancing biomedical innovations across various sectors, including immuno-oncology and medical device technologies, to enhance health outcomes globally. For more information about the program and enrollment instructions, shareholders can visit the company's website.




